Suramin treatment in hormone- and chemotherapy-refractory prostate cancer - anti-androgen treated patients

Author： Garcia-Schurmann J.M.   Schulze H.   Haupt G.   Pastor J.   Allolio B.   Senge T.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.53, Iss.3, 1999-03, pp. : 535-541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone-refractory Prostate Cancer? Anti-androgen Withdrawal and Intermittent Hormone Therapy

By Sciarra Alessandro   Casale Paolo   Colella Dario   Chiro Costantino Di   Silverio Franco Di  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 4, 1999-09 ,pp. : 211-216

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy for the Treatment of Hormone-Refractory Prostate Cancer

By Petrylak D.P.  

European Urology Supplements, Vol. 1, Iss. 2, 2002-05 ,pp. : 15-23

Elsevier

Access to resources Recommend Favorite

Prostate cancer risk after anti-androgen treatment for priapism

By Goetz Tabitha   Burnett Arthur  

International Urology and Nephrology, Vol. 46, Iss. 4, 2014-04 ,pp. : 757-760

Springer Publishing Company

Access to resources Recommend Favorite

Current Topics in the Treatment of Hormone-Refractory Prostate Cancer

By Iversen P.  

European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. : 3-8

Elsevier

Access to resources Recommend Favorite

Sequential chemotherapy with estramustine and vinorelbine for tumour cell synchronization in hormone refractory prostate cancer

By Kramer G.   Steiner G.   Herbst W.   Sokol P.   Zielinski C.   Djavan B.   Marberger M.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 25-25

Elsevier

Access to resources Recommend Favorite